Instituto de Oncologia Angel H. Roffo

Buenos Aires C1417DTB

0 studies enrolling now · 3 studies all time

What they study most

Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Endometrial Neoplasms, Pancreatic Cancer, Stage IA2 Cervical Cancer AJCC v6 and v7, Stage IB1 Cervical Cancer AJCC v6 and v7

Studies at this site

• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
• Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer — Stopped early
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed